Pharma-Bio Serv (PBSV) Net Cash Flow Growth (3y) (2013 - 2026)
Pharma-Bio Serv (PBSV) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 31.95% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 590.29% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -23.22% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -47.37% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 92.69% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -17.84% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 139.35% |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | -89.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -89.19% |
| Jan 31, 2026 | 32.46% |
| Oct 31, 2025 | -63.70% |
| Jul 31, 2025 | 19.34% |
| Apr 30, 2025 | -33.97% |
| Jan 31, 2025 | 31.34% |
| Oct 31, 2024 | -37.06% |
| Jul 31, 2024 | 90.78% |
| Apr 30, 2024 | 0.43% |
| Jan 31, 2024 | -61.43% |
| Oct 31, 2023 | 182.61% |
| Jul 31, 2023 | -84.48% |
| Apr 30, 2023 | 32.63% |
| Jan 31, 2023 | -218.88% |
| Oct 31, 2022 | -29.42% |
| Jul 31, 2022 | 54.81% |
| Apr 30, 2022 | -86.02% |
| Jan 31, 2022 | -104.70% |
| Oct 31, 2021 | 39.73% |
| Jul 31, 2021 | -36.31% |